drugset / Trial / NCT05278832
A Study of QLS31905 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, open-label design to evaluate the safety and tolerance of QLS31905 in patients with advanced solid tumors, together with an assessment of pharmacokinetic characteristics and efficacy.
Timeline
- Start
- 2021-10-25
- Primary completion
- 2022-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS31905 | Unknown | — | — |